iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) Shares Up 0% – Time to Buy?

Shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) shot up 0% on Friday . The stock traded as high as $25.40 and last traded at $25.38. 21,424 shares changed hands during mid-day trading, a decline of 34% from the average session volume of 32,320 shares. The stock had previously closed at $25.37.

iShares Genomics Immunology and Healthcare ETF Stock Up 0.0 %

The firm has a market cap of $148.47 million, a PE ratio of 2.29 and a beta of 1.14. The company has a 50-day simple moving average of $24.50 and a two-hundred day simple moving average of $24.13.

Institutional Trading of iShares Genomics Immunology and Healthcare ETF

A hedge fund recently bought a new stake in iShares Genomics Immunology and Healthcare ETF stock. Avior Wealth Management LLC purchased a new position in shares of iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm purchased 9,500 shares of the company’s stock, valued at approximately $234,000. Avior Wealth Management LLC owned about 0.16% of iShares Genomics Immunology and Healthcare ETF as of its most recent SEC filing.

iShares Genomics Immunology and Healthcare ETF Company Profile

The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.